Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2017, Article ID 3538568, 11 pages
https://doi.org/10.1155/2017/3538568
Research Article

A New Network-Based Strategy for Predicting the Potential miRNA-mRNA Interactions in Tumorigenesis

College of Chemistry, Sichuan University, Chengdu 610064, China

Correspondence should be addressed to Zhining Wen; moc.361@gninihz_w and Menglong Li; nc.ude.ucs@lmil

Received 29 April 2017; Accepted 10 July 2017; Published 2 August 2017

Academic Editor: Brian Wigdahl

Copyright © 2017 Jiwei Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Huang, X. J. Shen, Q. Zou, and Q. L. Zhao, “Biological functions of MicroRNAs,” Journal of Physiology and Biochemistry, vol. 67, no. 1, pp. 129–139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Chan and L. H. Wang, “Regulation of cancer metastasis by microRNAs,” Journal of Biomedical Science, vol. 22, no. 1, p. 9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Pasquinelli, “MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship,” Nature Reviews Genetics, vol. 13, no. 4, pp. 271–282, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Pereira, P. M. Rodrigues, P. M. Borralho, and C. M. Rodrigues, “Delivering the promise of miRNA cancer therapeutics,” Drug Discovery Today, vol. 18, no. 5-6, pp. 282–289, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. B. Reddy, “MicroRNA (miRNA) in cancer,” Cancer Cell International, vol. 15, no. 1, pp. 1–6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Garzon, M. Fabbri, A. Cimmino, G. A. Calin, and C. M. Croce, “MicroRNA expression and function in cancer,” Trends in Molecular Medicine, vol. 12, no. 12, p. 580, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. D. Jansson and A. H. Lund, “MicroRNA and cancer,” Molecular Oncology, vol. 6, no. 6, p. 590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Jin, C. J. Yang, X. Xu, J. N. Cao, Q. T. Feng, and J. Yang, “MiR-214 regulates the pathogenesis of patients with coronary artery disease by targeting VEGF,” Molecular and Cellular Biochemistry, vol. 402, no. 1, p. 111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Mi, D. Zhang, W. Jiang et al., “miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation,” Cancer Letters, vol. 389, p. 11, 2016. View at Publisher · View at Google Scholar
  10. C. G. Li, M. F. Pu, C. Z. Li et al., “MicroRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1,” Acta Pharmacologica Sinica, vol. 38, no. 1, pp. 110–119, 2017. View at Publisher · View at Google Scholar
  11. M. V. Iorio, M. Ferracin, C. G. Liu et al., “MicroRNA gene expression deregulation in human breast cancer,” Cancer Research, vol. 65, no. 16, pp. 7065–7070, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. V. Iorio and C. M. Croce, “MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review,” EMBO Molecular Medicine, vol. 4, no. 3, pp. 143–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Tyagi, S. Arora, S. K. Deshmukh, S. Singh, S. Marimuthu, and A. P. Singh, “Exploiting nanotechnology for the development of microRNA-based cancer therapeutics,” Journal of Biomedical Nanotechnology, vol. 12, no. 1, pp. 28–42, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Rupaimoole and F. J. Slack, “MicroRNA therapeutics: towards a new era for the management of cancer and other diseases,” Nature Reviews Drug Discovery, vol. 16, no. 3, pp. 203–222, 2017. View at Publisher · View at Google Scholar
  16. H. L. Janssen, H. W. Reesink, E. J. Lawitz et al., “Treatment of HCV infection by targeting microRNA,” New England Journal of Medicine, vol. 368, no. 18, pp. 1685–1694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. G. Bader, “miR-34–a microRNA replacement therapy is headed to the clinic,” Frontiers in Genetics, vol. 3, p. 120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Beg, A. J. Brenner, J. Sachdev et al., “Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors,” Investigational New Drugs, vol. 35, no. 2, pp. 1–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kozomara and S. Griffiths-Jones, “miRBase: annotating high confidence microRNAs using deep sequencing data,” Nucleic Acids Research, vol. 42, Database issue, pp. D68–D73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. B. John, A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks, “Human microRNA targets,” PLoS Biology, vol. 2, no. 11, article e363, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni et al., “DIANA-TarBase v7. 0: indexing more than half a million experimentally supported miRNA: mRNA interactions,” Nucleic Acids Research, vol. 43, Data issue, pp. D153–D159, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Li, C. Qiu, J. Tu et al., “HMDD v2. 0: a database for experimentally supported human microRNA and disease associations,” Nucleic Acids Research, vol. 42, Database issue, pp. D1070–D1074, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Hydbring and G. Badalian-Very, “Clinical applications of microRNAs,” F1000 Research, vol. 2, no. 2, p. 136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Friedman, T. Hastie, and R. Tibshirani, “Sparse inverse covariance estimation with the graphical lasso,” Biostatistics, vol. 9, no. 3, pp. 432–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Xie, Q. Ding, H. Han, and D. Wu, “miRCancer: a microRNA–cancer association database constructed by text mining on literature,” Bioinformatics, vol. 29, no. 5, pp. 638–644, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Jiang, Y. Wang, Y. Hao et al., “miR2Disease: a manually curated database for microRNA deregulation in human disease,” Nucleic Acids Research, vol. 37, Supplement 1, pp. D98–D104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Dennis Jr, B. T. Sherman, D. A. Hosack et al., “DAVID: database for annotation, visualization, and integrated discovery,” Genome Biology, vol. 4, no. 9, article R60, 2003. View at Publisher · View at Google Scholar
  28. Network TCGA, Cancer Genome Atlas Research Network, T. J. Ley et al., “Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia,” New England Journal of Medicine, vol. 368, no. 22, pp. 2059–2074, 2013. View at Publisher · View at Google Scholar
  29. Cancer Genome Atlas Network, D. C. Koboldt, R. S. Fulton et al., “Comprehensive molecular portraits of human breast tumors,” Nature, vol. 490, no. 7418, pp. 61–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. The Cancer Genome Atlas Research Network, “Comprehensive molecular characterization of clear cell renal cell carcinoma,” Nature, vol. 499, no. 7456, pp. 43–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Dobra, C. Hans, B. Jones, J. R. Nevins, G. Yao, and M. West, “Sparse graphical models for exploring gene expression data,” Journal of Multivariate Analysis, vol. 90, no. 1, pp. 196–212, 2004. View at Google Scholar
  32. G. Song, L. Han, and K. Xie, “Overlapping decomposition for Gaussian graphical modeling,” IEEE Transactions on Knowledge & Data Engineering, vol. 27, no. 8, pp. 2217–2230, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zuo, Y. Cui, G. Yu, R. Li, and H. W. Ressom, “Incorporating prior biological knowledge for network-based differential gene expression analysis using differentially weighted graphical LASSO,” BMC Bioinformatics, vol. 18, no. 1, p. 99, 2017. View at Publisher · View at Google Scholar
  34. X. F. Zhang, L. Ou-Yang, X. M. Zhao, and H. Yan, “Differential network analysis from cross-platform gene expression data,” Scientific Reports, vol. 6, article 34112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Xu, R. Jing, Y. Liu, Y. Dong, Z. Wen, and M. Li, “A new strategy for exploring the hierarchical structure of cancers by adaptively partitioning functional modules from gene expression network,” Scientific Reports, vol. 6, article 28720, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. S. Zheng, H. Zhang, X. J. Zhang et al., “MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia,” Oncogene, vol. 31, no. 1, p. 80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Bai, A. Guo, Z. Hong, and W. Kuai, “Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia,” Onco Targets Therapy, vol. 5, pp. 213–219, 2012, default. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Li, H. Huang, Y. Li et al., “Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML,” Blood, vol. 119, no. 10, p. 2314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. S. D. Selcuklu, M. T. Donoghue, K. Rehmet et al., “MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells,” Journal of Biological Chemistry, vol. 287, no. 35, pp. 29516–29528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Zhao, Y. Li, G. Lou et al., “MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells,” PloS One, vol. 7, no. 6, article e39102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Liu, M. Zhang, J. Qian et al., “miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal transition by targeting KRAS in renal cell carcinoma cells,” Dna & Cell Biology, vol. 34, no. 6, pp. 429–436, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Yamasaki, N. Seki, H. Yoshino et al., “MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway,” Journal of Urology, vol. 190, no. 3, pp. 1059–1068, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Balgkouranidou, A. Karayiannakis, D. Matthaios et al., “Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival,” Clinical Chemistry & Laboratory Medicine, vol. 51, no. 7, pp. 1505–1510, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Fu, C. Ren, H. Tan et al., “Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer,” Medicine, vol. 4, no. 3, pp. 143–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. F. Schmidt, “Drug target miRNAs: chances and challenges,” Trends in Biotechnology, vol. 32, no. 11, pp. 578–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. J. K. Nagpal, R. Rani, B. Trink, and K. S. Saini, “Targeting miRNAs for drug discovery: a new paradigm,” Current Molecular Medicine, vol. 10, no. 5, pp. 503–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. P. Nana-Sinkam and C. M. Croce, “Clinical applications for microRNAs in cancer,” Clinical Pharmacology & Therapeutics, vol. 93, no. 1, p. 98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. C. F. Thorn, T. E. Klein, and R. B. Altman, “PharmGKB: the pharmacogenomics knowledge base,” Methods in Molecular Biology, vol. 1015, pp. 311–320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. C. J. Mattingly, G. T. Colby, J. N. Forrest, and J. L. Boyer, “The Comparative Toxicogenomics Database (CTD),” Environmental Health Perspectives, vol. 111, no. 6, pp. 793–795, 2003. View at Google Scholar